Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31626 - 31650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	FAM162A	26355	downregulated	Cisplatin results in decreased expression of FAM162A mRNA	3q21.1	A20427
Cisplatin	Approved Investigational	FAM167A	83648	downregulated	Cisplatin results in decreased expression of FAM167A mRNA	8p23.1	A20427
Cisplatin	Approved Investigational	FAM171A1	221061	downregulated	Cisplatin results in decreased expression of FAM171A1 mRNA	10p13	A22204
Cisplatin	Approved Investigational	FAM20C	56975	downregulated	Cisplatin results in decreased expression of FAM20C mRNA	7p22.3	A22204
Cisplatin	Approved Investigational	FAM210A	125228	upregulated	Cisplatin results in increased expression of FAM210A mRNA	18p11.21	A20427
Cisplatin	Approved Investigational	FAM212B	55924	upregulated	Cisplatin results in increased expression of FAM212B mRNA	1p13.2	A22212 A20427
Cisplatin	Approved Investigational	FAM214A	56204	downregulated	Cisplatin results in decreased expression of FAM214A mRNA	15q21.2-q21.3	A20427
Cisplatin	Approved Investigational	FAM46A	55603	upregulated	Cisplatin results in increased expression of FAM46A mRNA	6q14.1	A22204
Cisplatin	Approved Investigational	FAM53C	51307	upregulated	Cisplatin results in increased expression of FAM53C mRNA	5q31.2	A22204
Cisplatin	Approved Investigational	FAM78B	149297	downregulated	Cisplatin results in decreased expression of FAM78B mRNA	1q24.1	A22204
Cisplatin	Approved Investigational	FAM84B	157638	upregulated	Cisplatin results in increased expression of FAM84B mRNA	8q24.21	A20427
Cisplatin	Approved Investigational	FAM89A	375061	upregulated	Cisplatin results in increased expression of FAM89A mRNA	1q42.2	A20427
Cisplatin	Approved Investigational	FANCC	2176	downregulated	Cisplatin results in decreased expression of FANCC mRNA	9q22.32	A22204 A22212
Cisplatin	Approved Investigational	FANCG	2189	upregulated	Cisplatin results in increased expression of FANCG mRNA	9p13.3	A22213
Cisplatin	Approved Investigational	FAR2	55711	downregulated	Cisplatin results in decreased expression of FAR2 mRNA	12p11.22	A22204
Cisplatin	Approved Investigational	FARS2	10667	downregulated	Cisplatin results in decreased expression of FARS2 mRNA	6p25.1	A22204
Cisplatin	Approved Investigational	FAS	355	upregulated	Cisplatin results in increased expression of and results in increased stability of FAS mRNA	10q23.31	A22249
Cisplatin	Approved Investigational	FAS	355	upregulated	Cisplatin results in increased expression of FAS mRNA	10q23.31	A22210 A22250 A22214 A22212
Cisplatin	Approved Investigational	FASLG	356	upregulated	Cisplatin results in increased expression of FASLG mRNA	1q24.3	A22250 A22214
Cisplatin	Approved Investigational	FASTK	10922	upregulated	Cisplatin results in increased expression of FASTK mRNA	7q36.1	A22236
Cisplatin	Approved Investigational	FBXO22	26263	upregulated	Cisplatin results in increased expression of FBXO22 mRNA	15q24.2	A20427
Cisplatin	Approved Investigational	FBXO30	84085	downregulated	Cisplatin results in decreased expression of FBXO30 mRNA	6q24.3	A20427
Cisplatin	Approved Investigational	FCHSD1	89848	downregulated	Cisplatin results in decreased expression of FCHSD1 mRNA	5q31.3	A22204
Cisplatin	Approved Investigational	FCHSD2	9873	downregulated	Cisplatin results in decreased expression of FCHSD2 mRNA	11q13.4	A22211
Cisplatin	Approved Investigational	FDXR	2232	upregulated	Cisplatin results in increased expression of FDXR mRNA	17q25.1	A22204 A22212

Displaying entries 31626 - 31650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability